Doxiproct, pommade rectale

7680389320123 CH-38932 pommade rectale
Doxiproct, pommade rectale
Doxiproct, pommade rectale
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
30
Selling units
30
Measure
g
Galenic form
pommade rectale
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/01/2026
Patient information leaflet
Français
27/01/2026
Patient information leaflet
Italien
27/01/2026
Summary of Product Characteristics
Allemand
02/06/2025
Summary of Product Characteristics
Français
02/06/2025
Summary of Product Characteristics
Italien
02/06/2025

Detailed composition

Substance Quantity Type Category
calcii dobesilas monohydricus
40.0 MG Substance Wirkstoff (Principe actif)
lidocaini hydrochloridum monohydricum
20.0 MG Substance Wirkstoff (Principe actif)
polysorbatum 80
- Substance HNIDK
E 310
- Substance ANTOX
E 320
0.15 MG Substance HBESI
acidum citricum
- Substance HNIDK
alcohol cetylicus
60.0 MG Substance HBESI
macrogolum 300
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
macrogolum 1500
- Substance HNIDK
macrogolum 4000
- Substance HNIDK
propylenglycolum
310.0 MG Substance HBESI

Authorization holder

OM Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
38932
Drug name
Doxiproct, pommade rectale
Galenic form
REKS
ATC Code
C05AD01
Authorization status
Z
Dispensing category
D
First authorization
02/04/1975
Authorization expiration date
31/12/9999
IT Number
02.09.1.
Domain
Human medicine

Package details

Description (FR)
Doxiproct pommade rectale 30 g
Description (DE)
Doxiproct Rektalsalbe 30 g
Market launch
02/04/1975
Narcotic (BTM)
No
Buy us a coffee Explore the data